Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for Amneal Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleChirag K. Patel
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Chirag K. Patel: trading record in brief
Chirag K. Patel (chief executive) discloses dealings in Amneal Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 15 December 2021 to 10 August 2026, the count stands at 5 filings.
The open-market record is one-sided, with 1 purchase worth €367k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 2 option exercises.
The latest filing, published on 12 August 2026, reports a share grant in Amneal Pharmaceuticals, Inc. The clock since the last published purchase (17 December 2021) now reads 1,766 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chirag K. Patel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,381,734 sharesClass A Common StockSEC:0001628280-26-056285:0
59,931 sharesClass A Common StockSEC:0001628280-26-015283:0
579,710 sharesClass A Common StockSEC:0001628280-25-010693:0
21,269,420 sharesClass A Common StockSEC:0001209191-23-054739:0
100,000 shares@ US$4.13100.0% of flowClass A Common StockSEC:0001209191-21-070259:0
Canonical exit: 15 Mar 2022 (T+90)
5 of 5 declarations
